Ms. Kathy Widmer is Executive Vice President, Chief Marketing Officer of Elizabeth Arden Inc., since November 2009. Prior to joining, Ms. Widmer was with Johnson & Johnson for 21 years where she held numerous positions, including, most recently, serving as Vice President, Marketing, McNeil Consumer Healthcare from May 2008 until November 2009. Prior to May 2008, Ms. Widmer served as Franchise Director and Product Director for various Johnson and Johnson consumer products, including Tylenol, Motrin, Reach Oral Care, and Pepcid from August 1996 until April 2008.
Chief Marketing Officer and Executive VP
Age: 49 EVP Since 2009
The company has return on total asset (ROA) of 6.78 % which means that it generated profit of $6.78 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 10.41 % meaning that it created $10.41 on every $100 dollars invested by stockholders.
The company currently holds 353.5 M in liabilities with Debt to Equity (D/E) ratio of 0.66 which is about average as compared to similar companies. Elizabeth Arden Inc has Current Ratio of 2.13 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Entity SummaryElizabeth Arden, Inc., a beauty solutions company, engages in the manufacture, distribution, marketing, and sale of fragrances, skin care, and cosmetic solutions worldwide. Elizabeth Arden Inc [RDEN] is traded on NASDAQ in USA. It is located in Elizabeth Arden, Inc.Miramar, FL and employs 2,357 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| RDEN Nasdaq
Elizabeth Arden Inc
Elizabeth Arden Inc has less than 31.81 (%) percent chance of experiencing financial distress in the next 2 years of operations.
Elizabeth price boundaries
Promote Elizabeth and Kathy Widmer